APP and Alzheimer disease: In addition to Aβ-mediated mechanisms, β-secretase-cleaved C-terminal fragment (β-CTF or C99), an intermittent β-metabolite of APP, may also contribute to faster forgetting in preclinical AD, via well-defined endosomal enlargement that precedes Aβ accumulation and accompanies accelerated endocytosis (Nixon, 2017).